Financhill
Sell
37

HBNC Quote, Financials, Valuation and Earnings

Last price:
$17.50
Seasonality move :
-4.4%
Day range:
$17.05 - $17.69
52-week range:
$12.70 - $19.07
Dividend yield:
3.68%
P/E ratio:
13.56x
P/S ratio:
7.19x
P/B ratio:
1.29x
Volume:
383.2K
Avg. volume:
406.9K
1-year change:
4.89%
Market cap:
$886M
Revenue:
$106.3M
EPS (TTM):
-$3.15
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $252.3M $284M $324.4M $359.5M $106.3M
Revenue Growth (YoY) -4.49% 12.58% 14.2% 10.81% -70.42%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $914K -- -$32.1M -$39.1M --
Operating Expenses -$102.4M -$105.6M -$33.8M -$27.4M $200.8M
Operating Income $102.4M $105.6M $33.8M $27.4M -$200.8M
 
Net Interest Expenses $10.3M $18.2M $47.7M $50M $33.2M
EBT. Incl. Unusual Items $102.4M $105.6M $33.8M $27.4M -$201.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $15.4M $12.2M $5.8M -$8.1M -$50.7M
Net Income to Company $87.1M $93.4M $28M $35.4M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $87.1M $93.4M $28M $35.4M -$150.5M
 
Basic EPS (Cont. Ops) $1.99 $2.14 $0.64 $0.81 -$3.14
Diluted EPS (Cont. Ops) $1.98 $2.14 $0.64 $0.80 -$3.15
Weighted Average Basic Share $43.8M $43.6M $43.6M $43.7M --
Weighted Average Diluted Share $44M $43.7M $43.8M $44.1M --
 
EBITDA -- -- -- -- --
EBIT $120.8M $142.1M $170.4M $195.2M -$67.9M
 
Revenue (Reported) $252.3M $284M $324.4M $359.5M $106.3M
Operating Income (Reported) $102.4M $105.6M $33.8M $27.4M -$200.8M
Operating Income (Adjusted) $120.8M $142.1M $170.4M $195.2M -$67.9M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $65M $77.4M $63.3M $64.4M $100.8M
Revenue Growth (YoY) -11.6% 19.17% -18.28% 1.76% 56.46%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -$31.6M -$39.1M --
Operating Expenses -$25M -$23.8M $18.8M $21.9M -$32.7M
Operating Income $25M $23.8M -$18.8M -$21.9M $32.7M
 
Net Interest Expenses $2.5M $7.6M $12.9M $11.9M $4.3M
EBT. Incl. Unusual Items $25.5M $23.8M -$18.8M -$21.9M $32.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $4.1M $2.6M $6.4M -$11.1M $5.8M
Net Income to Company $21.4M $21.2M -$25.2M -$10.9M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $21.4M $21.2M -$25.2M -$10.9M $26.9M
 
Basic EPS (Cont. Ops) $0.49 $0.49 -$0.58 -$0.25 $0.53
Diluted EPS (Cont. Ops) $0.49 $0.48 -$0.58 -$0.25 $0.53
Weighted Average Basic Share $43.5M $43.6M $43.6M $43.7M $51M
Weighted Average Diluted Share $43.7M $43.7M $43.6M $43.7M $51.3M
 
EBITDA -- -- -- -- --
EBIT $29.6M $42.2M $22.5M $18.3M $58.5M
 
Revenue (Reported) $65M $77.4M $63.3M $64.4M $100.8M
Operating Income (Reported) $25M $23.8M -$18.8M -$21.9M $32.7M
Operating Income (Adjusted) $29.6M $42.2M $22.5M $18.3M $58.5M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $256.7M $283.2M $323.7M $359.2M $112.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $914K -- -$32.1M -$39.1M --
Operating Expenses -$102M -$105.6M -$39M -$28.2M $200.8M
Operating Income $102M $105.6M $39M $28.2M -$200.8M
 
Net Interest Expenses $10.4M $18.2M $47.7M $49.4M $33.2M
EBT. Incl. Unusual Items $102.4M $105.6M $39M $27.4M -$201.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $15.4M $12.2M $11M -$8.1M -$50.7M
Net Income to Company $87.1M $93.4M $28M $35.4M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $87.1M $93.4M $28M $35.4M -$150.5M
 
Basic EPS (Cont. Ops) $1.99 $2.14 $0.64 $0.81 -$3.15
Diluted EPS (Cont. Ops) $1.98 $2.14 $0.64 $0.80 -$3.15
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT $120.8M $142.1M $175.6M $195.2M -$67.9M
 
Revenue (Reported) $256.7M $283.2M $323.7M $359.2M $112.8M
Operating Income (Reported) $102M $105.6M $39M $28.2M -$200.8M
Operating Income (Adjusted) $120.8M $142.1M $175.6M $195.2M -$67.9M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $256.7M $283.2M $323.7M $359.2M $112.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $914K -- -$32.1M -$39.1M -$407K
Operating Expenses -$102M -$105.6M -$39M -$28.2M $200.8M
Operating Income $102M $105.6M $39M $28.2M -$200.8M
 
Net Interest Expenses $10.4M $18.2M $47.7M $49.4M $33.2M
EBT. Incl. Unusual Items $102.4M $105.6M $39M $27.4M -$201.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $15.4M $12.2M $11M -$8.1M -$50.7M
Net Income to Company $87.1M $93.4M $28M $35.4M $44.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $87.1M $93.4M $28M $35.4M -$150.5M
 
Basic EPS (Cont. Ops) $1.99 $2.14 $0.64 $0.81 -$3.15
Diluted EPS (Cont. Ops) $1.98 $2.14 $0.64 $0.80 -$3.15
Weighted Average Basic Share $175.2M $174.3M $174.5M $174.8M $185.9M
Weighted Average Diluted Share $175.9M $174.8M $174.9M $175.7M $186.6M
 
EBITDA -- -- -- -- --
EBIT $120.8M $142.1M $175.6M $195.2M -$67.9M
 
Revenue (Reported) $256.7M $283.2M $323.7M $359.2M $112.8M
Operating Income (Reported) $102M $105.6M $39M $28.2M -$200.8M
Operating Income (Adjusted) $120.8M $142.1M $175.6M $195.2M -$67.9M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $593.5M $123.5M $526.5M $92.3M $66.8M
Short Term Investments $1.2B $997.6M $547.3M $233.7M --
Accounts Receivable, Net $26.1M $35.3M $38.7M $39.7M --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $628M $163.8M $567.4M $333.9M $174.8M
 
Property Plant And Equipment $93.4M $92.7M $94.6M $93.9M $92.8M
Long-Term Investments $57.3M $80.2M $92M $377.2M $128.1M
Goodwill $154.6M $155.2M $155.2M $155.2M --
Other Intangibles $20.9M $17.2M $13.6M $10.2M --
Other Long-Term Assets -- -- -- -- --
Total Assets $7.4B $7.9B $7.9B $7.8B $6.4B
 
Accounts Payable $2.2M $5.4M $22.2M $11.1M --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.1B $5.4B $5.5B $5.1B $1.2B
 
Long-Term Debt $828.3M $516.2M $812.9M $1.1B $316M
Capital Leases -- -- -- -- --
Total Liabilities $6.7B $7.2B $7.2B $7B $5.7B
 
Common Stock -- -- -- -- --
Other Common Equity Adj $7.3M -$106.2M -$66.6M -$36.3M --
Common Equity $723.2M $677.4M $718.8M $763.6M $688.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $723.2M $677.4M $718.8M $763.6M $688.3M
 
Total Liabilities and Equity $7.4B $7.9B $7.9B $7.8B $6.4B
Cash and Short Terms $1.8B $1.1B $1.1B $527.8M --
Total Debt $828.3M $1.1B $1.3B $1.3B $316M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $593.5M $123.5M $526.5M $92.3M $66.8M
Short Term Investments $1.2B $997.6M $547.3M $233.7M --
Accounts Receivable, Net $26.1M $35.3M $38.7M $39.7M --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $628M $163.8M $567.4M $333.9M $174.8M
 
Property Plant And Equipment $93.4M $92.7M $94.6M $93.9M $92.8M
Long-Term Investments $57.3M $80.2M $92M $377.2M $128.1M
Goodwill $154.6M $155.2M $155.2M $155.2M --
Other Intangibles $20.9M $17.2M $13.6M $10.2M --
Other Long-Term Assets -- -- -- -- --
Total Assets $7.4B $7.9B $7.9B $7.8B $6.4B
 
Accounts Payable $2.2M $5.4M $22.2M $11.1M --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.1B $5.4B $5.5B $5.1B $1.2B
 
Long-Term Debt $828.3M $516.2M $812.9M $1.1B $316M
Capital Leases -- -- -- -- --
Total Liabilities $6.7B $7.2B $7.2B $7B $5.7B
 
Common Stock -- -- -- -- --
Other Common Equity Adj $7.3M -$106.2M -$66.6M -$36.3M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $723.2M $677.4M $718.8M $763.6M $688.3M
 
Total Liabilities and Equity $7.4B $7.9B $7.9B $7.8B $6.4B
Cash and Short Terms $1.8B $1.1B $1.1B $527.8M --
Total Debt $828.3M $1.1B $1.3B $1.3B $316M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $68.5M $87.1M $93.4M $28M $35.4M
Depreciation & Amoritzation $10.6M $9.8M $10.8M $10.9M $10.3M
Stock-Based Compensation $132K $1.8M $2.5M $3.6M $4.6M
Change in Accounts Receivable -$2.6M -$4.2M -$9.2M -$3.4M -$1M
Change in Inventories -- -- -- -- --
Cash From Operations $61.5M $90.4M $83.6M $81.4M $70.5M
 
Capital Expenditures $5.9M $1.4M $56.4M $7.8M $5.1M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$475.1M -$328.9M -$1B $337M -$116.9M
 
Dividends Paid (Ex Special Dividend) $21.2M $24.8M $27.8M $28.3M $28.3M
Special Dividend Paid
Long-Term Debt Issued $192.6M $244.6M $1.2B $866.1M $512.8M
Long-Term Debt Repaid -$221.4M -$76.4M -$755.6M -$657.3M -$563.5M
Repurchase of Common Stock -- $7.6M -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $564.4M $582.3M $455.5M -$15.4M -$190.8M
 
Beginning Cash (CF) $98.8M $249.7M $593.5M $123.5M $526.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $150.9M $343.8M -$470M $403M -$233.1M
Ending Cash (CF) $249.7M $593.5M $123.5M $526.5M $293.4M
 
Levered Free Cash Flow $55.6M $89M $27.2M $73.7M $65.5M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $21.4M $21.2M -$25.2M -$10.9M --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $1.8M $692K $939K $1.7M --
Change in Accounts Receivable -$1.4M -$5.2M -$860K -$381K --
Change in Inventories -- -- -- -- --
Cash From Operations $25.3M $14.4M $13M $17.3M --
 
Capital Expenditures $978K $1.7M $1.3M $1.8M --
Cash Acquisitions $616.8M -- -- -- --
Cash From Investing -$206.3M -$115.3M $387.3M $204M --
 
Dividends Paid (Ex Special Dividend) $6.6M $7.1M $7.1M $7M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $17M $172.8M $278.2M -- --
Long-Term Debt Repaid -$11.3M -$68M -$278.4M -$403K --
Repurchase of Common Stock $7M -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$197.4M $114.7M -$48.9M -$166.8M --
 
Beginning Cash (CF) $971.8M $109.7M $175.1M $234.8M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$378.3M $13.8M $351.4M $58.6M --
Ending Cash (CF) $593.5M $123.5M $526.5M $293.4M --
 
Levered Free Cash Flow $24.4M $12.7M $11.6M $15.5M --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $87.1M $93.4M $28M $35.4M --
Depreciation & Amoritzation $13.9M $13.1M $12M $12.3M --
Stock-Based Compensation $1.8M $2.5M $3.6M $4.6M --
Change in Accounts Receivable -$4.2M -$9.2M -$3.4M -$1M --
Change in Inventories -- -- -- -- --
Cash From Operations $90.4M $83.6M $81.4M $70.5M --
 
Capital Expenditures $1.4M $56.4M $7.8M $5.1M $4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$328.9M -$1B $337M -$116.9M --
 
Dividends Paid (Ex Special Dividend) $24.8M $27.8M $28.3M $28.3M --
Special Dividend Paid
Long-Term Debt Issued $244.6M $1.2B $866.1M $512.8M --
Long-Term Debt Repaid -$76.4M -$755.6M -$657.3M -$563.5M --
Repurchase of Common Stock $7.6M -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $582.3M $455.5M -$15.4M -$190.8M --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $343.8M -$470M $403M -$233.1M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $89M $27.2M $73.7M $65.5M --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $87.1M $93.4M $28M $35.4M $44.6M
Depreciation & Amoritzation $2.7M $2.7M $2.6M $2.6M $5.4M
Stock-Based Compensation $1.8M $2.5M $3.6M $4.6M $1.2M
Change in Accounts Receivable -$4.2M -$9.2M -$3.4M -$1M $17K
Change in Inventories -- -- -- -- --
Cash From Operations $90.4M $83.6M $81.4M $70.5M $45.7M
 
Capital Expenditures $1.4M $56.4M $7.8M $5.1M $4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$328.9M -$1B $337M -$116.9M $1B
 
Dividends Paid (Ex Special Dividend) $24.8M $27.8M $28.3M $28.3M $21.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $244.6M $1.2B $866.1M $512.8M $370M
Long-Term Debt Repaid -$76.4M -$755.6M -$657.3M -$563.5M -$632M
Repurchase of Common Stock $7.6M -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $582.3M $455.5M -$15.4M -$190.8M -$1B
 
Beginning Cash (CF) $2.1B $933M $662.4M $1.2B $463.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $343.8M -$470M $403M -$233.1M $164.8M
Ending Cash (CF) $2.4B $463M $1.1B $945.5M $307.6M
 
Levered Free Cash Flow $89M $27.2M $73.7M $65.5M $41.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Is Palantir Stock Going to Crash?
Is Palantir Stock Going to Crash?

AI and data analytics major Palantir (NASDAQ:PLTR) has become something…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
50
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
52
CVLT alert for Jan 27

Commvault Systems, Inc. [CVLT] is down 30.53% over the past day.

Sell
47
AGYS alert for Jan 27

Agilysys, Inc. [AGYS] is down 20.71% over the past day.

Buy
71
GLSI alert for Jan 27

Greenwich LifeSciences, Inc. [GLSI] is up 4.02% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock